标题
Molecular Therapeutics in Development for Epidermolysis Bullosa: Update 2020
作者
关键词
-
出版物
Molecular Diagnosis & Therapy
Volume 24, Issue 3, Pages 299-309
出版商
Springer Science and Business Media LLC
发表日期
2020-04-23
DOI
10.1007/s40291-020-00466-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Consensus re‐classification of inherited epidermolysis bullosa and other disorders with skin fragility
- (2020) C. Has et al. BRITISH JOURNAL OF DERMATOLOGY
- Genomics‐based treatment in a patient with two overlapping heritable skin disorders: Epidermolysis bullosa and acrodermatitis enteropathica
- (2020) Hassan Vahidnezhad et al. HUMAN MUTATION
- Context-Dependent Strategies for Enhanced Genome Editing of Genodermatoses
- (2020) Oliver Patrick March et al. Cells
- Meeting Report: The First Global Congress on Epidermolysis Bullosa, EB2020 London – Toward Treatment and Cure
- (2020) Jemima E. Mellerio et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Clinically Relevant Correction of Recessive Dystrophic Epidermolysis Bullosa by Dual sgRNA CRISPR/Cas9-Mediated Gene Editing
- (2019) Jose Bonafont et al. MOLECULAR THERAPY
- Identification of rigosertib for the treatment of recessive dystrophic epidermolysis bullosa-associated squamous cell carcinoma
- (2019) Velina S. Atanasova et al. CLINICAL CANCER RESEARCH
- Revertant Mosaic Fibroblasts in Recessive Dystrophic Epidermolysis Bullosa
- (2019) K. Twaroski et al. BRITISH JOURNAL OF DERMATOLOGY
- Fibroblast activation and abnormal extracellular matrix remodelling as common hallmarks in three cancer‐prone genodermatoses
- (2019) E. Chacón‐Solano et al. BRITISH JOURNAL OF DERMATOLOGY
- Epidermolysis bullosa: Advances in research and treatment
- (2019) Christine Prodinger et al. EXPERIMENTAL DERMATOLOGY
- Stem cell competition orchestrates skin homeostasis and ageing
- (2019) Nan Liu et al. NATURE
- Collagen VII Expression is Required in Both Keratinocytes and Fibroblasts for Anchoring Fibril Formation in Bilayer Engineered Skin Substitutes
- (2019) Dorothy M. Supp et al. CELL TRANSPLANTATION
- Profound immunodeficiency with severe skin disease explained by concomitant novel CARMIL2 and PLEC1 loss-of-function mutations
- (2019) Maria E. Maccari et al. CLINICAL IMMUNOLOGY
- Gene Therapy for Epidermolysis Bullosa
- (2019) M. Peter Marinkovich et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Natural history of growth and anaemia in children with epidermolysis bullosa: A retrospective cohort study
- (2019) A. Reimer et al. BRITISH JOURNAL OF DERMATOLOGY
- EBGene trial: Patient pre‐selection outcomes for the European GENEGRAFT ex vivo phase I/II gene therapy trial for recessive dystrophic epidermolysis bullosa
- (2019) S. Gaucher et al. BRITISH JOURNAL OF DERMATOLOGY
- Combined anti‐inflammatory and low‐dose antiproliferative therapy for squamous cell carcinomas in recessive dystrophic epidermolysis bullosa
- (2019) A. Reimer et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Natural exon skipping sets the stage for antisense oligonucleotide-mediated exon skipping as therapy for dystrophic epidermolysis bullosa
- (2019) Jeroen Bremer et al. Molecular Therapy-Nucleic Acids
- EGFR inhibition for metastasized cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa
- (2019) Andrea Diociaiuti et al. Orphanet Journal of Rare Diseases
- CRISPR/Cas9-based targeted genome editing for correction of recessive dystrophic epidermolysis bullosa using iPS cells
- (2019) Joanna Jacków et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Next generation sequencing identifies double homozygous mutations in two distinct genes (EXPH5 and COL17A1 ) in a patient with concomitant simplex and junctional epidermolysis bullosa
- (2018) Hassan Vahidnezhad et al. HUMAN MUTATION
- CRISPR/Cas9-Based Cellular Engineering for Targeted Gene Overexpression
- (2018) Mark Osborn et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- EB2017—Progress in Epidermolysis Bullosa Research toward Treatment and Cure
- (2018) Jouni Uitto et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Injury- and inflammation-driven skin fibrosis: The paradigm of epidermolysis bullosa
- (2018) Alexander Nyström et al. MATRIX BIOLOGY
- PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma
- (2018) Michael R. Migden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gentamicin inducesLAMB3nonsense mutation readthrough and restores functional laminin 332 in junctional epidermolysis bullosa
- (2018) Vadim Lincoln et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ex vivo COL7A1 correction for Recessive Dystrophic Epidermolysis Bullosa using CRISPR/Cas9 and Homology Directed Repair
- (2018) Araksya Izmiryan et al. Molecular Therapy-Nucleic Acids
- An ex-vivo RNA trans -splicing strategy to correct human generalized severe epidermolysis bullosa simplex
- (2018) P. Peking et al. BRITISH JOURNAL OF DERMATOLOGY
- CRISPR/Cas9-Mediated In Situ Correction of LAMB3 Gene in Keratinocytes Derived from a Junctional Epidermolysis Bullosa Patient
- (2018) Daniela Benati et al. MOLECULAR THERAPY
- Decorin counteracts disease progression in mice with recessive dystrophic epidermolysis bullosa
- (2018) Francesca Cianfarani et al. MATRIX BIOLOGY
- The administration of high-mobility group box 1 fragment prevents deterioration of cardiac performance by enhancement of bone marrow mesenchymal stem cell homing in the delta-sarcoglycan-deficient hamster
- (2018) Takashi Kido et al. PLoS One
- Gentamicin induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients
- (2017) David T. Woodley et al. JOURNAL OF CLINICAL INVESTIGATION
- 906 Systemic HMGB1 administration ameliorates cutaneous and non-cutaneous manifestations in a dystrophic epidermolysis bullosa model mouse
- (2017) T. Shimbo et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Closure of a Large Chronic Wound through Transplantation of Gene-Corrected Epidermal Stem Cells
- (2017) Johann W. Bauer et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Amlexanox Enhances Premature Termination Codon Read-Through in COL7A1 and Expression of Full Length Type VII Collagen: Potential Therapy for Recessive Dystrophic Epidermolysis Bullosa
- (2017) Velina S. Atanasova et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Cut and Paste: Efficient Homology-Directed Repair of a Dominant Negative KRT14 Mutation via CRISPR/Cas9 Nickases
- (2017) Thomas Kocher et al. MOLECULAR THERAPY
- COL7A1 Editing via CRISPR/Cas9 in Recessive Dystrophic Epidermolysis Bullosa
- (2017) Stefan Hainzl et al. MOLECULAR THERAPY
- Regeneration of the entire human epidermis using transgenic stem cells
- (2017) Tobias Hirsch et al. NATURE
- An RNA-targeted therapy for dystrophic epidermolysis bullosa
- (2017) Patricia Peking et al. NUCLEIC ACIDS RESEARCH
- Efficient in vivo gene editing using ribonucleoproteins in skin stem cells of recessive dystrophic epidermolysis bullosa mouse model
- (2017) Wenbo Wu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Amelioration of junctional epidermolysis bullosa due to exon skipping
- (2016) C. Kowalewski et al. BRITISH JOURNAL OF DERMATOLOGY
- RNA-based therapies for genodermatoses
- (2016) Olivier Bornert et al. EXPERIMENTAL DERMATOLOGY
- Construction and validation of an RNA trans-splicing molecule suitable to repair a large number of COL7A1 mutations
- (2016) B Tockner et al. GENE THERAPY
- Safety and Wound Outcomes Following Genetically Corrected Autologous Epidermal Grafts in Patients With Recessive Dystrophic Epidermolysis Bullosa
- (2016) Zurab Siprashvili et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Targeted Exon Skipping Restores Type VII Collagen Expression and Anchoring Fibril Formation in an In Vivo RDEB Model
- (2016) Sandrina Turczynski et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Analysis of the functional consequences of targeted exon deletion in COL7A1 reveals prospects for dystrophic epidermolysis bullosa therapy
- (2016) Olivier Bornert et al. MOLECULAR THERAPY
- Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
- (2016) Robert L. Ferris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Site-specific genome editing for correction of induced pluripotent stem cells derived from dominant dystrophic epidermolysis bullosa
- (2016) Satoru Shinkuma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antisense Oligonucleotide-mediated Exon Skipping as a Systemic Therapeutic Approach for Recessive Dystrophic Epidermolysis Bullosa
- (2016) Jeroen Bremer et al. Molecular Therapy-Nucleic Acids
- ACOL7A1variant leading to in-frame skipping of exon 15 attenuates disease severity in recessive dystrophic epidermolysis bullosa
- (2015) A. Schwieger-Briel et al. BRITISH JOURNAL OF DERMATOLOGY
- Management of cutaneous squamous cell carcinoma in patients with epidermolysis bullosa: best clinical practice guidelines
- (2015) J.E. Mellerio et al. BRITISH JOURNAL OF DERMATOLOGY
- Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms
- (2015) A. Nystrom et al. EMBO Molecular Medicine
- Proinflammatory Cytokines and Antiskin Autoantibodies in Patients With Inherited Epidermolysis Bullosa
- (2015) Giuseppina Annicchiarico et al. MEDICINE
- Systemic high-mobility group box 1 administration suppresses skin inflammation by inducing an accumulation of PDGFRα+ mesenchymal cells from bone marrow
- (2015) Eriko Aikawa et al. Scientific Reports
- Monozygotic twins discordant for recessive dystrophic epidermolysis bullosa phenotype highlight the role of TGF-β signalling in modifying disease severity
- (2014) Teresa Odorisio et al. HUMAN MOLECULAR GENETICS
- Mechanisms of Natural Gene Therapy in Dystrophic Epidermolysis Bullosa
- (2014) Dimitra Kiritsi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Inherited epidermolysis bullosa: Updated recommendations on diagnosis and classification
- (2014) Jo-David Fine et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Aminoglycosides Restore Full-length Type VII Collagen by Overcoming Premature Termination Codons: Therapeutic Implications for Dystrophic Epidermolysis Bullosa
- (2014) Jon Cogan et al. MOLECULAR THERAPY
- Induced pluripotent stem cells from human revertant keratinocytes for the treatment of epidermolysis bullosa
- (2014) N. Umegaki-Arao et al. Science Translational Medicine
- Use of cetuximab as an adjuvant agent to radiotherapy and surgery in recessive dystrophic epidermolysis bullosa with squamous cell carcinoma
- (2013) M. Kim et al. BRITISH JOURNAL OF DERMATOLOGY
- Collagen VII plays a dual role in wound healing
- (2013) Alexander Nyström et al. JOURNAL OF CLINICAL INVESTIGATION
- The Pathogenetic Role of IL-1β in Severe Epidermolysis Bullosa Simplex
- (2013) Verena Wally et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Intravenously Injected Recombinant Human Type VII Collagen Homes to Skin Wounds and Restores Skin Integrity of Dystrophic Epidermolysis Bullosa
- (2013) David T. Woodley et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Successful therapeutic transplantation of revertant skin in epidermolysis bullosa
- (2013) Antoni Gostyński et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- A Lack of Premature Termination Codon Read-Through Efficacy of PTC124 (Ataluren) in a Diverse Array of Reporter Assays
- (2013) Stuart P. McElroy et al. PLOS BIOLOGY
- Fibroblast-Derived Dermal Matrix Drives Development of Aggressive Cutaneous Squamous Cell Carcinoma in Patients with Recessive Dystrophic Epidermolysis Bullosa
- (2012) Y.-Z. Ng et al. CANCER RESEARCH
- Complexities of TGF-β Targeted Cancer Therapy
- (2012) Erin C. Connolly et al. International Journal of Biological Sciences
- Natural Gene Therapy May Occur in All Patients with Generalized Non-Herlitz Junctional Epidermolysis Bullosa with COL17A1 Mutations
- (2012) Anna M.G. Pasmooij et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Punch grafting of chronic ulcers in patients with laminin-332–deficient, non-Herlitz junctional epidermolysis bullosa
- (2012) Wing Yan Yuen et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Rescue of nonsense mutations by amlexanox in human cells
- (2012) Sara Gonzalez-Hilarion et al. Orphanet Journal of Rare Diseases
- Kindler syndrome: Extension of FERMT1 mutational spectrum and natural history
- (2011) Cristina Has et al. HUMAN MUTATION
- Molecular mechanisms of phenotypic variability in junctional epidermolysis bullosa
- (2011) D. Kiritsi et al. JOURNAL OF MEDICAL GENETICS
- PDGFR -positive cells in bone marrow are mobilized by high mobility group box 1 (HMGB1) to regenerate injured epithelia
- (2011) K. Tamai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cetuximab Therapy of Metastasizing Cutaneous Squamous Cell Carcinoma in a Patient with Severe Recessive Dystrophic Epidermolysis Bullosa
- (2009) Andreas W. Arnold et al. DERMATOLOGY
- Epidermolysis bullosa and the risk of life-threatening cancers: The National EB Registry experience, 1986-2006
- (2008) Jo-David Fine et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- EGFR Antagonists in Cancer Treatment
- (2008) Fortunato Ciardiello et al. NEW ENGLAND JOURNAL OF MEDICINE
- A frequent functional SNP in theMMP1promoter is associated with higher disease severity in recessive dystrophic epidermolysis bullosa
- (2007) Matthias Titeux et al. HUMAN MUTATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started